Hirohito Yamazaki

Kanazawa, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Long-term efficacy and safety of romiplostim plus immunosuppressive therapy as first-line treatment in patients with aplastic anaemia: 2-year interim analysis of observational study of two clinical trials.

Long-term efficacy and safety of romiplostim plus immunosuppressive therapy as first-line treatment in patients with aplastic anaemia: 2-year interim analysis of observational study of two clinical trials.

Journal: British journal of haematology

Published: December 05, 2025

Loss-Prone HLA Class I Alleles Inform Outcomes of Early Hematopoietic Cell Transplantation in Acquired Aplastic Anemia.

Loss-Prone HLA Class I Alleles Inform Outcomes of Early Hematopoietic Cell Transplantation in Acquired Aplastic Anemia.

Journal: American journal of hematology

Published: June 20, 2025

Epcoritamab as bridging therapy to successful second allogeneic HSCT in relapsed DLBCL after UCBT and CAR T cell therapy.

Epcoritamab as bridging therapy to successful second allogeneic HSCT in relapsed DLBCL after UCBT and CAR T cell therapy.

Journal: International journal of hematology

Published: June 18, 2025

Transient lupus anticoagulant induced by adenovirus cystitis in a bone marrow transplant recipient.

Transient lupus anticoagulant induced by adenovirus cystitis in a bone marrow transplant recipient.

Journal: International journal of hematology

Published: January 23, 2025

Pharmacotherapy for aplastic anemia

Pharmacotherapy for aplastic anemia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: November 06, 2024

Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia.

Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia.

Journal: Blood advances

Published: September 18, 2024

High-dose romiplostim for donor-type aplasia.

High-dose romiplostim for donor-type aplasia.

Journal: Annals of hematology

Published: August 05, 2024

Significance of absolute neutrophil count before allogeneic hematopoietic stem cell transplantation in adult patients with aplastic anemia.

Significance of absolute neutrophil count before allogeneic hematopoietic stem cell transplantation in adult patients with aplastic anemia.

Journal: Annals of hematology

Published: January 27, 2024

Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantation.

Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantation.

Journal: Bone marrow transplantation

Published: November 13, 2023

Reference guide for the treatment of aplastic anemia: key points of the 2022 revision

Reference guide for the treatment of aplastic anemia: key points of the 2022 revision

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: October 04, 2023

Correction: Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15.

Correction: Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15.

Journal: Leukemia

Published: August 25, 2023

Comparison of Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus Umbilical Cord Blood Transplantation in Adult Patients with Aplastic Anemia.

Comparison of Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus Umbilical Cord Blood Transplantation in Adult Patients with Aplastic Anemia.

Journal: Transplantation and cellular therapy

Published: July 13, 2023

Showing 1-12 of 62

Last Updated: 09/26/2026